Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

834.04
+7.400.90%
Post-market: 834.040.00000.00%19:58 EDT
Volume:786.92K
Turnover:656.91M
Market Cap:85.87B
PE:20.63
High:847.00
Open:835.74
Low:826.64
Close:826.64
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.27
T/O Rate:0.80%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.71
PE(LYR):20.11

Loading ...

Movement Alert|Regeneron Pharmaceuticals Falls 3.2% in Pre-Market Trading, Multiple Banks Cut Target Prices Amid Q2 Earnings Warning

Market Focus
·
Jul 16

Booking, Alphabet, and 7 Other Stocks to Buy Ahead of Earnings

Dow Jones
·
Jul 16

Regeneron’s dupilumab granted orphan drug designation

TIPRANKS
·
Jul 15

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

These Biggest and "Least Loved" Stocks Are the Ones to Pick Ahead of Earnings

Dow Jones
·
Jul 13

Regeneron price target lowered to $854 from $855 at Piper Sandler

TIPRANKS
·
Jul 09

Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855

MT Newswires Live
·
Jul 09

Regeneron Pharma is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 09

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

MT Newswires Live
·
Jul 08

Regeneron price target lowered to $730 from $788 at Morgan Stanley

TIPRANKS
·
Jul 08

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 08

Regeneron Director Arthur F. Ryan Sells 200 Shares Worth $130,030

Reuters
·
Jul 08

Regeneron Pharma is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Jul 07

Movement Alert|Regeneron Pharmaceuticals Rises 3.06% in Regular Trading, Selected for FDA Accelerated New Production Facility Review Program

Market Focus
·
Jul 07

Regeneron price target lowered to $769 from $778 at Truist

TIPRANKS
·
Jul 07

RBC Capital Adjusts Regeneron Pharmaceuticals Price Target to $696 From $707, Maintains Sector Perform Rating

MT Newswires Live
·
Jul 07

Regeneron Pharmaceuticals Inc : Truist Securities Cuts Target Price to $769 from $778

THOMSON REUTERS
·
Jul 07

Regeneron Pharma is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Jul 06

HSBC Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $990

MT Newswires Live
·
Jul 06

Regeneron price target lowered to $750 from $785 at Cantor Fitzgerald

TIPRANKS
·
Jul 06